AndreaBozzo/ceres-open-data-index huggingface dataset:
Climate Shield Cutthroat Trout (50% Brook Trout), 2040 (Feature Layer)

This feature class represents the mid-century (2030-2059) scenario for cutthroat trout, derived from the Climate Shield fish distribution models. These models provide stream-specific probabilistic predictions about the occurrence of juvenile bull trout and cutthroat trout in association with three different scenarios for climate change and brook trout invasions. These datasets indicate all potential cold-water habitats less than 11 degrees Celsius. The attribute fields CT_0BRK - CT_100BRK indicate the probabilities of cutthroat trout occurrence within a cold-water habitat based on the prevalence of brook trout at 0%, 25%, 50%, 75%, or 100% of the sites within a habitat. The probabilities were predicted using the Climate Shield native trout models developed from known species occurrence in greater than 500 cold-water streams. The stream centerlines were based on the National Hydrography Dataset (NHD) but were modified for purposes of modeling and cross-walking to other datasets.
Video-Based 3D pose estimation for residential roofing-dataset

To protect residential roofing construction workers from both fatal and musculoskeletal injuries, it is necessary to assess the musculoskeletal and biomechanical risks in residential roofing tasks. This undertaking requires accurate information of workers’ 3D body positions to analyze kinematics and kinetics of the human body. In this study, we proposed a novel 2- stage motion estimation approach based on a convolution neural network to estimate residential roofer’s body positions using three-view video data. Instead of pursuing end-to- end training, our approach includes two stages: (1) use a multi-view model to estimate the 3D pose in a single frame; (2) use a multi-frame model to apply temporal convolutions to refine the multi-view outputs. The performance of the approach was evaluated by comparing our estimation with the gold-standard marker-based 3D human pose estimation (“ground truth”). The evaluation results show that our marker-free video-based approach can accurately capture the 3D posture of workers during the common roofing task and the proposed multi-frame model can effectively improve the precision of the coordinate sequence. The values of mean per joint position error of estimated human position before and after processing by the multi-frame model are 27.93 and 24.81 mm, respectively. These results prove that the proposed marker-free motion capture estimation approach can efficiently and accurately locate 3D body joints and pave the way for future onsite musculoskeletal motion analysis during roofing activities.
NNDSS - TABLE 1V. Malaria to Measles, Indigenous

NNDSS - TABLE 1V. Malaria to Measles, Indigenous - 2022. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notes:

•	These are weekly cases of selected infectious national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables available at https://www.cdc.gov/nndss/data-statistics/index.html. Cases reported by state health departments to CDC for weekly publication are subject to ongoing revision of information and delayed reporting. Therefore, numbers listed in later weeks may reflect changes made to these counts as additional information becomes available. Case counts in the tables are presented as published each week. See also Guide to Interpreting Provisional and Finalized NNDSS Data at https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
• Notices, errata, and other notes are available in the Notice To Data Users page at https://wonder.cdc.gov/nndss/NTR.html.
•	The list of national notifiable infectious diseases and conditions and their national surveillance case definitions are available at https://ndc.services.cdc.gov/. This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved by CSTE for national surveillance.

Footnotes:

*Case counts for reporting years 2021 and 2022 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
Compound 530709: 5-Bromovaleric acid, 2,6-dimethylnon-1-en-3-yn-5-yl ester

Chemical compound data from PubChem database. IUPAC Name: 2,6-dimethylnon-1-en-3-yn-5-yl 5-bromopentanoate. Molecular Formula: C16H25BrO2. Molecular Weight: 329.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2020 Methodological Summary and Definitions

Use this summary report to properly interpret 2020 NSDUH estimates of substance use and mental health issues. The report accompanies theannual detailed tablesand covers overall methodology, key definitions for measures and terms used in 2020 NSDUH reports and tables, and selected analyses of the measures and how they should be interpreted.The report is organized into six chapters:Introduction.Description of the survey, including information about the sample design, data collection procedures, and key aspects of data processing such as development of the analysis weights.Technical details on the statistical methods and measurement, such as suppression criteria for unreliable estimates, statistical testing procedures, issues around data accuracy, and measurement issues for selected substance use and mental health measures.Special topics related to prescription psychotherapeutic drugs.A comparison between NSDUH and other sources of data on substance use and mental health issues, including data sources for populations outside the NSDUH target population.A more in-depth view of special methodological issues for the 2020 NSDUH, including those related to methodological changes made because of the Coronavirus 2019 Pandemic.An appendix covers key definitions used in NSDUH reports and tables.
Compound 529465: 2,2,2-Trifluoro-n-(2-methoxyphenyl)acetamide

Chemical compound data from PubChem database. IUPAC Name: 2,2,2-trifluoro-N-(2-methoxyphenyl)acetamide. Molecular Formula: C9H8F3NO2. Molecular Weight: 219.16. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530017: Benzaldehyde, 3,4-methylenedioxy, methoxime

Chemical compound data from PubChem database. IUPAC Name: 1-(1,3-benzodioxol-5-yl)-N-methoxymethanimine. Molecular Formula: C9H9NO3. Molecular Weight: 179.17. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2014 CMHS Uniform Reporting System (URS) Table for Massachusetts

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Massachusetts. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 526544: 4-[(7-hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl)methoxy]-3-propan-2-ylpent-4-ene-2,3-diol

Chemical compound data from PubChem database. IUPAC Name: 4-[(7-hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl)methoxy]-3-propan-2-ylpent-4-ene-2,3-diol. Molecular Formula: C16H27NO4. Molecular Weight: 297.39. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526946: 3-Ethylthiophene-2-carbaldehyde

Chemical compound data from PubChem database. IUPAC Name: 3-ethylthiophene-2-carbaldehyde. Molecular Formula: C7H8OS. Molecular Weight: 140.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
SHIP Babies with Low Birth Weight 2010-2021

Babies with Low Birth Weight - This indicator shows the percentage of live births that are a low birth weight (2500 grams or less). Babies born with a low birth weight are at increased risk for serious health consequences including disabilities and death. Low birth weight babies weigh less than 2,500 grams (5.5 pounds). Maryland’s low birth weight percentage is higher than the national average. <a href ="https://health.maryland.gov/pophealth/Documents/SHIP/SHIP%20Lite%20Data%20Details/Babies%20with%20Low%20Birth%20Rate.pdf" > Link to Data Details </a>
Indicators for 2010B

Payment files reflect a change in the conversion factor as a result of the Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, which President Obama signed into law on June 25, 2010. This legislation provides for a 2.2 percent update to the 2010 Medicare Physician Fee Schedule (MPFS), effective for dates of service June 1, 2010, through November 30, 2010. For 2010A: Payment files reflect changes as a result of practice expense (PE) and malpractice (MP) relative value unit (RVU) corrections and provisions of the Patient Protection and Affordable Care Act (the Affordable Care Act), as modified by the Health Care and Education Reconciliation Act of 2010, which President Obama signed into law on March 23, 2010, and March 30, 2010, respectively.
Compound 525409: Hexane, 1-[(1-methylethyl)thio]-

Chemical compound data from PubChem database. IUPAC Name: 1-propan-2-ylsulfanylhexane. Molecular Formula: C9H20S. Molecular Weight: 160.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Treatment of disseminated granuloma annulare with fumaric acid esters

Background
          Granuloma annulare is a granulomatous disease of unknown etiology. Various therapies have been tried in disseminated granuloma annulare (DGA), including corticosteroids, several variants of psoralen plus ultraviolet-A radiation, ultraviolet- A1 radiation, systemic retinoids, and dapsone, with variable success. We report a patient with recalcitrant DGA who was treated with fumaric acid esters (FAE).
        
        
          Case presentation
          A 40-year old Caucasian woman presented with a 25-year history of recalcitrant DGA. On both legs and the abdomen there were erythematous annular plaques. She was treated with FAE in tablet form using two formulations differing in strength (low strength tablets: 30 mg dimethylfumarate, 67 mg monoethylfumarate Ca salt, 5 mg monoethylfumarate Mg salt, 3 mg monoethylfumarate Zn salt; high strength tablets: 120 mg dimethylfumarate, 87 mg monoethylfumarate Ca salt, 5 mg monoethylfumarate Mg salt, 3 mg monoethylfumarate Zn salt). After three-month therapy, an almost complete clearance of skin lesions was achieved. With the exception of temporary lymphopenia, no adverse effects were observed. The patient remained in remission during a six-month follow up period.
        
        
          Conclusions
          Our observation has demonstrated that FAE is a potentially beneficial therapeutic option for patients with recalcitrant DGA. However controlled trials are necessary to fully explore the efficacy, optimal dosage, and safety of FAE in the management of DGA.
Supporting Evidence-Based Home Visitation Programs to Prevent Child Abuse and Neglect Project: Rhode Island KIDS COUNT

Location:

Providence, Pawtucket, and Central Falls, Rhode Island

Home Visiting Program Selected:

Nurse Family Partnership

Home Visiting Target Population:

Families with multiple risks for child maltreatment expecting their first child.

Project Overview:
RI KIDS COUNT will lead a statewide Rhode Island (RI) Nurse-Family Partnership (NFP) Initiative to develop the infrastructure required to support NFP replication in three cities with large concentrations of families and children at risk for child maltreatment. The ultimate goal is to have NFP services available statewide. Children's Friend & Service will serve as the key program implementation partner at the NFP anchor site. Other partners focusing on infrastructure development and systems building targeted on leveraging state funds and engaging stakeholders and the public include the RI Department of Children, Youth and Families; the RI Department of Health, the RI Department of Human Services; and the NFP National Service Office. Bradley/Hasbro Children's Research Center at Brown University Medical School will conduct an experimental evaluation that includes assessments when children are 3 and 24 months old. The evaluation will examine implementation of the state infrastructure development activities, measure process indicators and child and family level outcomes, and analyze costs.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E401070-T1: [Translated] COMPOSITIONS CONTAINING AMINO ACIDS, SUITABLE FOR WOUND HEALING, IN PARTICULAR FOR THE TREATMENT OF THE EYE

Amino-acid-based compositions, suitable in therapy for the healing of wounds and lesions, in particular for application in the ophthalmic field, comprising: proline, glycine and lysine, up to 80 wt % on the total of all the amino acids or active ingredients envisaged; one or more of the amino acids selected in the group comprising leucine, isoleucine and threonine, in an overall quantity of between 2 wt % and 60 wt % on the total of all the amino acids or active ingredients envisaged. Preferably envisaged are also other essential amino acids, in particular methionine, phenyl alanine, histidine, tryptophan, and non-essential amino acids, in particular tyrosine and cyst(e)ine (i.e., cystine and cysteine). Other amino acids can be added, provided that their sum is a percentage lower than 20 wt % with respect to the sum of the other active ingredients, and less than 10 wt % for each individual amino acid.
Compound 526312: 2,3,4,7,9-Pentabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,3,6,7,8-pentabromodibenzofuran. Molecular Formula: C12H3Br5O. Molecular Weight: 562.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Computational prediction of membrane-tethered transcription factors

Background
          Sequestration of transcription factors in the membrane is emerging as an important mechanism for the regulation of gene expression. A handful of membrane-spanning transcription factors has been previously identified whose access to the nucleus is regulated by proteolytic cleavage from the membrane. To investigate the existence of other transmembrane transcription factors, we analyzed computationally all proteins in SWISS-PROT/TrEMBL for the combined presence of a DNA-binding domain and a transmembrane segment.
        
        
          Results
          Using Pfam hidden Markov models and four transmembrane-prediction programs, we identified with high confidence 76 membrane-spanning transcription factors in SWISS-PROT/TrEMBL. Analysis of the distribution of two proteins predicted by our method, MTJ1 and DMRT2, confirmed their localization to intracellular membrane compartments. Furthermore, elimination of the predicted transmembrane segment led to nuclear localization for each of these proteins.
        
        
          Conclusions
          Our analysis uncovered a wealth of predicted membrane-spanning transcription factors that are structurally and taxonomically diverse, 56 of which lack experimental annotation. Seventy-five of the proteins are modular in structure, suggesting that a single proteolysis may be sufficient to liberate a DNA-binding domain from the membrane. This study provides grounds for investigations into the stimuli and mechanisms that release this intriguing class of transcription factors from membranes.
Compound 528148: 5-Sec-butyl-3-methyl-2-(methylthio)pyrazine

Chemical compound data from PubChem database. IUPAC Name: 5-butan-2-yl-3-methyl-2-methylsulfanylpyrazine. Molecular Formula: C10H16N2S. Molecular Weight: 196.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Systematic review of the use of honey as a wound dressing

Objective
          To investigate topical honey in superficial burns and wounds though a systematic review of randomised controlled trials.
        
        
          Data sources
          Cochrane Library, MEDLINE, EMBASE, PubMed, reference lists and databases were used to seek randomised controlled trials. Seven randomised trials involved superficial burns, partial thickness burns, moderate to severe burns that included full thickness injury, and infected postoperative wounds.
        
        
          Review methods
          Studies were randomised trials using honey, published papers, with a comparator. Main outcomes were relative benefit and number-needed-to-treat to prevent an outcome relating to wound healing time or infection rate.
        
        
          Results
          One study in infected postoperative wounds compared honey with antiseptics plus systemic antibiotics. The number needed to treat with honey for good wound healing compared with antiseptic was 2.9 (95% confidence interval 1.7 to 9.7). Five studies in patients with partial thickness or superficial burns involved less than 40% of the body surface. Comparators were polyurethane film, amniotic membrane, potato peel and silver sulphadiazine. The number needed to treat for seven days with honey to produce one patient with a healed burn was 2.6 (2.1 to 3.4) compared with any other treatment and 2.7 (2.0 to 4.1) compared with potato and amniotic membrane. For some or all outcomes honey was superior to all these treatments. Time for healing was significantly shorter for honey than all these treatments. The quality of studies was low.
        
        
          Conclusion
          Confidence in a conclusion that honey is a useful treatment for superficial wounds or burns is low. There is biological plausibility.
Compound 528969: 3-Cyclohexen-1-ol, 4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-

Chemical compound data from PubChem database. IUPAC Name: 4-(3-hydroxybut-1-enyl)-3,5,5-trimethylcyclohex-3-en-1-ol. Molecular Formula: C13H22O2. Molecular Weight: 210.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529270: 1-Hexyne, 3,4-dimethyl

Chemical compound data from PubChem database. IUPAC Name: 3,4-dimethylhex-1-yne. Molecular Formula: C8H14. Molecular Weight: 110.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 60 years and older, United States

Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 60 Years and Older, United States

• Estimated Number of RSV vaccinations among adults 60 years and older is assessed through IQVIA (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices.

• Starting in September 2023, the CDC recommended the RSV vaccine for adults 60 years and older.
Compound 527046: N-Heptyl-N-methyl-benzamide

Chemical compound data from PubChem database. IUPAC Name: N-heptyl-N-methylbenzamide. Molecular Formula: C15H23NO. Molecular Weight: 233.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525902: N,N-Dimethyl-N'-heptyl-isobutyramidine

Chemical compound data from PubChem database. IUPAC Name: N'-heptyl-N,N,2-trimethylpropanimidamide. Molecular Formula: C13H28N2. Molecular Weight: 212.37. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528249: 2-Ethyl-3,5-dimethylthiophene

Chemical compound data from PubChem database. IUPAC Name: 2-ethyl-3,5-dimethylthiophene. Molecular Formula: C8H12S. Molecular Weight: 140.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.